News DeskDubai, UAE – LEO Pharma, a leader in medical dermatology, has partnered with the Emirates Dermatology Society (EDS) to launch Hand in hand, a campaign focused on raising awareness about Chronic Hand Eczema (CHE) in the UAE. This collaboration aims to establish CHE as a recognized condition, address unmet needs, and improve treatment access. Together, LEO Pharma and EDS are working to enhance understanding of CHE among healthcare providers, patients, and the public to ultimately improve quality of life for those affected.
Chronic Hand Eczema, affecting 4.7%* of the global population, significantly impacts patients’ daily lives, from physical pain to psychological challenges. Hand in hand highlights this often-overlooked condition, underscoring the need for specialized treatment and support.
Ahmed Safwat, General Manager of LEO Pharma UAE, remarked, “At LEO Pharma, we are committed to addressing high unmet needs in medical dermatology. By partnering with EDS, we aim to elevate understanding and care for CHE, bringing greater recognition to its impact and helping those affected.”
The campaign’s objectives focus on medical education, public awareness, and treatment access. Hand In Hand empowers patients and their families with resources, aiming to foster greater empathy and support across the medical community. These efforts will enhance access to treatments.
Dr. Muna Al Murrawi, President of the Emirates Dermatology Society, added, “The Emirates Dermatology Society is excited to collaborate with LEO Pharma to shed light on CHE and improve standard of care in the UAE. By promoting awareness, we’re addressing critical gaps for those impacted by this often-overlooked condition.”
Denise Maria Antaki, Senior Healthcare Commercial Advisor at the Danish Embassy in the UAE, stated, “This partnership is a vital step toward raising CHE awareness. Chronic Hand Eczema has been misunderstood and often neglected. We aim to ensure that CHE patients receive the support and access to care they need.”
As this campaign progresses, LEO Pharma and EDS remain committed to working hand-in-hand to create impactful changes that will benefit the CHE patient community and establish CHE as a recognized and prioritized condition within UAE healthcare.
